2009
DOI: 10.3390/ijerph6061917
|View full text |Cite
|
Sign up to set email alerts
|

Gamma Hydroxybutyric Acid (GHB) for the Treatment of Alcohol Dependence: A Review

Abstract: Gamma-hydroxybutyric acid (GHB) is a short-chain fatty acid structurally similar to the inhibitory neurotransmitter γ-aminobutyric acid. Clinical trials have demonstrated that 50–100 mg/kg of GHB fractioned into three or six daily doses is able to suppress alcohol withdrawal symptoms and facilitates the maintenance of abstinence from alcohol. These studies have also shown that GHB craving episodes are a very limited phenomenon (about 10–15%). Thus, physicians with access should consider the clinical efficacy o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
46
0

Year Published

2010
2010
2015
2015

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 66 publications
(46 citation statements)
references
References 64 publications
0
46
0
Order By: Relevance
“…Because there is accumulating evidence that GHB plays an important role in the sleeping disorder narcolepsy (Robinson and Keating, 2007), and hypotheses have emerged about involvement of GHB in alcoholism (Caputo et al, 2009) and neurodegenerative disorders and depression (Mamelak, 2007(Mamelak, , 2009, we propose that suitably radiolabeled BnOPh-GHB derivatives could provide important tools in future in vivo positron emission tomography or single photon emission computed tomography imaging for the characterization of GHB binding sites, their distribution in the human brain, and the relevance for substance abuse and neurological disorders.…”
Section: Or [mentioning
confidence: 99%
See 1 more Smart Citation
“…Because there is accumulating evidence that GHB plays an important role in the sleeping disorder narcolepsy (Robinson and Keating, 2007), and hypotheses have emerged about involvement of GHB in alcoholism (Caputo et al, 2009) and neurodegenerative disorders and depression (Mamelak, 2007(Mamelak, , 2009, we propose that suitably radiolabeled BnOPh-GHB derivatives could provide important tools in future in vivo positron emission tomography or single photon emission computed tomography imaging for the characterization of GHB binding sites, their distribution in the human brain, and the relevance for substance abuse and neurological disorders.…”
Section: Or [mentioning
confidence: 99%
“…1). Clinically, the drug is used for treatment of narcolepsy (Robinson and Keating, 2007) or alcohol-withdrawal symptoms (Caputo et al, 2009), but it is also a popular recreational drug occasionally used as a "date rape drug" because of its euphoric, prosocial, relaxing, and sleep-inducing effects (Anderson et al, 2006;Drasbek et al, 2006).…”
mentioning
confidence: 99%
“…GHB, a metabolite and a structural analog of GABA, is found endogenously throughout the mammalian brain in micromolar concentrations [5,11,32]. GHB has been used therapeutically in the treatment of sleep disorders [19,29,60,64], and to treat alcoholism and alcohol-withdrawal symptoms [7]. Illicit use of GHB has been reported in humans [66].…”
Section: Introductionmentioning
confidence: 99%
“…Although it has been abandoned as anaesthetic agent in most countries because of side effects such as seizures and coma, it is still registered in Germany (Somsanit®). The sodium salt of GHB, known under the international drug name sodium oxybate, has a role in the treatment of narcolepsy with cataplexy (Xyrem®) and of opiate and alcohol withdrawal (Alcover®) [7][8][9][10][11].…”
Section: Troductiomentioning
confidence: 99%